NIH-funded research R01 grant

Mitochondria–lysosome stress in aging and Alzheimer’s disease

Official title: A novel mitochondria-to-lysosome stress signaling pathway in degenerative disease and aging

Funded at Upstate Medical University · NIH-11324248 · Data updated 2026-11-12

This project looks at how stress signals between mitochondria and lysosomes harm brain cells in Alzheimer's and other age-related diseases to guide future treatments.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUpstate Medical University
NIH-funded
Lab location1 site (Syracuse, United States)
Project startAugust 1, 2023
Project endApril 30, 2028
Funding year2026
Award (this year)$407,500
NIH project number5R01AG082803-04
Project IDNIH-11324248 on NIH RePORTER

Who could benefit from this research

Could help

People with Alzheimer's disease or other age-related neurodegenerative conditions, or those willing to provide biological samples, would be most relevant for future participation or follow-up studies.

Less likely to help

Individuals without neurodegenerative disease or those seeking immediate clinical treatment are unlikely to receive direct, short-term benefit from this basic laboratory research.

What this research studies

This work brings together two labs to study how damaged mitochondria send stress signals that overwhelm the cell's waste system (lysosomes) and lead to cell decline. Scientists will use cell models, yeast, and other laboratory systems to track a process called mitochondrial precursor overaccumulation stress (mPOS) and its effects on lysosomal function. The team will map the molecular steps of this mitochondria-to-lysosome signaling pathway to identify points that could be targeted by future therapies. Findings aim to explain why neurons fail in Alzheimer’s and related disorders and to point toward ways to protect brain cells.

Why it matters

Potential benefit: If successful, this work could reveal new targets for drugs that slow or prevent cell damage in Alzheimer’s and other age-related neurodegenerative diseases.

How similar studies have gone: Prior laboratory studies have linked mitochondrial and lysosomal dysfunction and described mPOS, but this specific mitochondria-to-lysosome signaling pathway and its role in human neurodegeneration are largely novel.

Where this research is happening

  • Upstate Medical University
    Syracuse, United States
    Active

Researchers

  • Principal investigator: Chen, Xin Jie — Upstate Medical University
  • Study coordinator: Chen, Xin Jie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.